Wire Stories
-
497Everen Limited (formerly Oil Insurance Limited) reveals its brand identity
HAMILTON, Bermuda–(BUSINESS WIRE)–Following a rebranding announcement, Everen reveals its brand-new visual identity. The new logo and elements of the brand have been...
-
527Australian Red Cross Taps Boomi to Help Raise $27M For Flood-affected Communities
Boomi provides data connectivity and technical support to ensure success of the recent Australia Unites Telethon Following recent wins in Australia and...
-
520DL E&C to Advance to Global Market Using Korea-Developed CCUS Technologies
– DL E&C signed an MOU with KEPCO KEPRI to establish a mutual exchange of technology and collaboration system. – It will...
-
500WNS Joins AWS� ISV Accelerate Program
NEW YORK & LONDON & MUMBAI, India–(BUSINESS WIRE)–$WNS #AWS–WNS (Holdings) Limited (NYSE: WNS), a leading provider of global Business Process Management (BPM)...
-
510Enfusion Appoints Oleg Movchan Interim Chief Executive Officer
Reiterates 2022 Third Quarter and Full Year Revenue Guidance NEW YORK & LONDON & HONG KONG–(BUSINESS WIRE)–Enfusion, Inc. (“Enfusion”) (NYSE: ENFN), a...
-
436Mobile Devices Markets in China: Demand to Grow at 10% Yearly Through 2031 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Mobile Devices Markets in China” report has been added to ResearchAndMarkets.com’s offering. China’s demand for Mobile Devices has grown at...
-
658Lenovo Evolves Small Businesses
RALEIGH, N.C.–(BUSINESS WIRE)–Today, Lenovo announced the new iteration of Evolve Small � an initiative built to champion and promote small businesses across...
-
489Alkegen Announces Plans to Increase Micro-Fine Glass Fiber Capacity To Support Growing Battery and Filtration Demand
Company expanding micro-fine glass fiber capacity in US, Europe, and China to support future growth BUFFALO, N.Y.–(BUSINESS WIRE)–Alkegen, one of the largest...
-
482Pillar Biosciences Receives China National Medical Products Administration (NMPA) Approval for oncoRevealTM Dx Colon Cancer Assay
– Highly-accurate, tissue-based, next-generation sequencing (NGS) test approved in China as a companion diagnostic for targeted colon cancer therapies NATICK, Mass.–(BUSINESS WIRE)–Pillar...
-
492Solasia Announces Launch of Darvias� in Japan
TOKYO–(BUSINESS WIRE)–Solasia Pharma K.K. (TOKYO:4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter �Solasia�) officially announced today that an organoarsenic drug...
